S&P 500   3,333.69 (-0.80%)
DOW   27,686.91 (-0.38%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   204.05 (-2.02%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   435.81 (-2.42%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,376.17 (-2.99%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   467.50 (-3.29%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   3,333.69 (-0.80%)
DOW   27,686.91 (-0.38%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   204.05 (-2.02%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   435.81 (-2.42%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,376.17 (-2.99%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   467.50 (-3.29%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   3,333.69 (-0.80%)
DOW   27,686.91 (-0.38%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   204.05 (-2.02%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   435.81 (-2.42%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,376.17 (-2.99%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   467.50 (-3.29%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   3,333.69 (-0.80%)
DOW   27,686.91 (-0.38%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   204.05 (-2.02%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   435.81 (-2.42%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,376.17 (-2.99%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   467.50 (-3.29%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
Log in

NASDAQ:COLLCollegium Pharmaceutical SEC Filings & 10K Form

$18.92
+0.03 (+0.16 %)
(As of 08/11/2020 04:00 PM ET)
Add
Compare
Today's Range
$18.72
Now: $18.92
$19.58
50-Day Range
$15.78
MA: $17.14
$18.38
52-Week Range
$10.41
Now: $18.92
$25.59
Volume426,741 shs
Average Volume555,731 shs
Market Capitalization$653.23 million
P/E RatioN/A
Dividend YieldN/A
Beta0.97

SEC Filings

Collegium Pharmaceutical (NASDAQ:COLL) SEC Filings

DateFilerForm TypeView
07/14/2020
3:06 PM
Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2020
4:00 PM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2020
5:58 PM
Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
3:26 PM
Collegium Pharmaceutical (Issuer)
SANTINI GINO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
3:25 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
3:24 PM
Collegium Pharmaceutical (Issuer)
Hirsch David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
3:23 PM
Collegium Pharmaceutical (Issuer)
Freund John Gordon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
3:23 PM
Collegium Pharmaceutical (Issuer)
Fallon John A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
3:18 PM
Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2020
3:27 PM
Collegium Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/22/2020
8:58 AM
Collegium Pharmaceutical (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G
04/09/2020
3:09 PM
Collegium Pharmaceutical (Filer)
Form DEFA14A
04/03/2020
3:16 PM
Collegium Pharmaceutical (Issuer)
Malamut Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2020
11:15 PM
Collegium Pharmaceutical (Filer)
Form EFFECT
03/25/2020
3:01 PM
Collegium Pharmaceutical (Filer)
Form PRE 14A
03/18/2020
3:16 PM
Collegium Pharmaceutical (Issuer)
Kuhlmann Shirley R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2020
3:27 PM
Collegium Pharmaceutical (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/27/2020
3:09 PM
Collegium Pharmaceutical (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/21/2020
3:02 PM
Camber Capital Management LP (Filed by)
Collegium Pharmaceutical (Subject)
Form SC 13G
02/13/2020
2:09 PM
Collegium Pharmaceutical (Subject)
MACQUARIE GROUP LTD (Filed by)
Form SC 13G/A
02/12/2020
3:27 PM
Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
3:25 PM
Collegium Pharmaceutical (Issuer)
Kuhlmann Shirley R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
3:22 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
3:44 PM
Collegium Pharmaceutical (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
02/10/2020
6:33 AM
Collegium Pharmaceutical (Filer)
Form 424B5
02/07/2020
3:41 PM
Collegium Pharmaceutical (Issuer)
Fleming Alison B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2020
1:55 PM
Collegium Pharmaceutical (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SC 13G/A
01/24/2020
12:38 PM
Collegium Pharmaceutical (Subject)
Frazier Healthcare VI, L.P. (Filed by)
Form SC 13D/A
01/22/2020
3:29 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2020
3:27 PM
Collegium Pharmaceutical (Issuer)
Fleming Alison B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2020
3:26 PM
Brannelly Paul (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2020
3:12 PM
Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
3:27 PM
Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2020
3:05 PM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2019
4:26 PM
Collegium Pharmaceutical (Issuer)
Freund John Gordon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2019
3:16 PM
Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2019
3:33 PM
Collegium Pharmaceutical (Issuer)
Hirsch David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2019
3:32 PM
Collegium Pharmaceutical (Issuer)
Fleming Alison B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2019
11:15 PM
Collegium Pharmaceutical (Filer)
Form EFFECT
11/06/2019
3:04 PM
Collegium Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2019
3:01 PM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2019
3:31 PM
Collegium Pharmaceutical (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/18/2019
3:06 PM
Collegium Pharmaceutical (Issuer)
Kuhlmann Shirley R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2019
5:16 PM
Collegium Pharmaceutical (Issuer)
Hirsch David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2019
3:47 PM
Collegium Pharmaceutical (Issuer)
Fleming Alison B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2019
3:46 PM
Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2019
3:45 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
4:02 PM
Collegium Pharmaceutical (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/07/2019
3:03 PM
Collegium Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2019
3:01 PM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2019
3:04 PM
Collegium Pharmaceutical (Issuer)
Fleming Alison B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2019
3:03 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2019
3:02 PM
Brannelly Paul (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2019
3:22 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2019
3:08 PM
Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
5:15 PM
Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
5:05 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
3:17 PM
Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
3:04 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
3:03 PM
Collegium Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2019
3:02 PM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
3:00 PM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
7:52 AM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
5:55 PM
Collegium Pharmaceutical (Issuer)
Fallon John A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
5:52 PM
Collegium Pharmaceutical (Issuer)
Schroeder Theodore R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
5:50 PM
Collegium Pharmaceutical (Issuer)
Hirsch David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
5:48 PM
Collegium Pharmaceutical (Issuer)
Freund John Gordon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
5:44 PM
Collegium Pharmaceutical (Issuer)
SANTINI GINO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
5:42 PM
BOHLIN GAREN G (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
5:39 PM
Collegium Pharmaceutical (Issuer)
Melincoff Gwen A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2019
3:24 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
3:12 PM
Collegium Pharmaceutical (Issuer)
Malamut Richard (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/19/2019
4:41 PM
Collegium Pharmaceutical (Issuer)
Kuhlmann Shirley R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2019
4:36 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2019
3:01 PM
Collegium Pharmaceutical (Filer)
Form DEF 14A
02/27/2019
3:01 PM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
2:39 PM
Collegium Pharmaceutical (Subject)
MACQUARIE GROUP LTD (Filed by)
Form SC 13G
02/14/2019
10:07 AM
Collegium Pharmaceutical (Subject)
Rock Springs Capital Management LP (Filed by)
Form SC 13G/A
02/12/2019
4:12 PM
Collegium Pharmaceutical (Subject)
Longitude Capital Partners, LLC (Filed by)
Form SC 13G/A
02/12/2019
8:14 AM
Collegium Pharmaceutical (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
02/11/2019
4:06 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2019
4:03 PM
Collegium Pharmaceutical (Issuer)
Fleming Alison B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2019
9:22 AM
BlackRock Inc. (Filed by)
Collegium Pharmaceutical (Subject)
Form SC 13G/A
01/29/2019
3:46 PM
Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
3:42 PM
Collegium Pharmaceutical (Issuer)
Fleming Alison B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
3:39 PM
Brannelly Paul (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
3:37 PM
Collegium Pharmaceutical (Issuer)
Kuhlmann Shirley R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
3:33 PM
Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
2:30 PM
Collegium Pharmaceutical (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SC 13G
01/23/2019
3:17 PM
Collegium Pharmaceutical (Issuer)
Fleming Alison B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
3:14 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
3:13 PM
Brannelly Paul (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2019
3:16 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
7:00 AM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2018
4:09 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2018
4:05 PM
Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2018
3:19 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2018
3:16 PM
Collegium Pharmaceutical (Issuer)
Freund John Gordon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2018
10:27 AM
Collegium Pharmaceutical (Filer)
Form D
Notice of Exempt Offering of Securities 
11/08/2018
3:06 PM
Collegium Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.